Non-vascular Stents Market Report

Non-vascular Stents Market Analysis By Product [Gastrointestinal (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), Pulmonary, Urological Stents], And Segment Forecasts, 2018 - 2025

  • Published Date: Oct, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-663-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 104

Industry Insights

The global non-vascular stents market size was valued at USD 916.1 million in 2016 and is expected to grow at a CAGR of 5.1% during the forecast period. Growing geriatric population, rise in prevalence of chronic & other diseases, and increase in per capita healthcare spending are expected to boost the non-vascular stents market during the forecast period. In addition, increase in adoption of minimally invasive surgeries worldwide, is also anticipated to support the market growth.

U.S. non-vascular stents market

Geriatric population is prone to develop chronic diseases such as lung cancer, pancreatic cancer, gallbladder cancer, colon/colorectal cancer, stroke, asthma, Chronic Obstructive Pulmonary Disease (COPD), chronic pancreatitis, prostate cancer, glaucoma, and this is expected to facilitate increase in demand for non-vascular stents over the forecast period. WHO estimates that global population aged 60 years and above will rise from 841.0 million in 2013 to over 2.0 billion by 2050.

Prevalence of gastrointestinal cancer is constantly increasing across the globe, which is expected to nurture the non-vascular stents market growth. The GI Cancer Institute of Australia reported that about 24,000 Australians are diagnosed with this disease every year. Moreover, as per statistics published by the American Cancer Society, in 2016, nearly 26,370 individuals were diagnosed with stomach cancer in the U.S. It further states that around 28,000 new cases of stomach cancer will be diagnosed by 2017.

The World Bank Group stated that the global per capita healthcare expenditure increased by around 55.0% from 1996 to 2014. Currently, the healthcare expenditure of the U.S. is around 2.4 times higher than the global average and is anticipated to increase by 68.0% in the next 10 years. In addition, the IBM Global Business Services executive report stated that the per capita healthcare expenditure of the U.S. was nearly USD 9,400.0 in the year 2014. This rise in per capita healthcare expenditure across the globe is expected to spur the market growth over the forecast period.

Product Insights

The products analyzed in this study include gastrointestinal, pulmonary or airway, urological, and other stents. The gastrointestinal stents segment is further categorized into biliary, duodenal, colonic, pancreatic, and esophageal stents. Also, the pulmonary stents are further classified into the silicone airway and metallic airway stents.

The urological stents segment emerged as the largest segment due to increasing prevalence of ureteral diseases, such as renal calculi or kidney stone, urinary tract infection, and prostate cancer, across the world. A surge in the number of ureteroscopy and ureterorenoscopy, lithotripsy, and schistosomiasis procedures across the world is anticipated to propel the demand for urological stents.

Global non-vascular stents market

The gastrointestinal stents segment is expected to register comparatively higher CAGR over the forecast period. This can be attributed to the growing incidence of gastrointestinal cancer, such as cancer of the stomach, esophagus, gall bladder, pancreas, liver, small intestine, bowel, and anus, coupled with increasing preference of patients for minimally invasive surgeries around the globe.

Worldwide rise in incidence of biliary disease such as bile duct cancer, gallstone disease, and primary biliary cholangitis is expected to positively impact the growth of biliary stents market over the forecast period.

Regional Insights

North America held over 32.0% share in the market in 2016 owing to increasing prevalence of lung cancer, glaucoma, central airway obstruction, COPD, asthma, and other chronic diseases in the U.S. and Canada. Local presence of major market players, target population, and robust healthcare infrastructure in the region further supported the dominance of this region.

Europe is also expected to hold a substantial market share during the forecast period due to the flourishing medical technology sector and increasing prevalence of gastric cancer in the EU5 countries. On the other hand, Asia Pacific is expected to register higher CAGR over the forecast period as compared to other regions due to favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.

Competitive Outlook

Some of the major players in this industry are Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL, INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; and Glaukos Corporation.

These players focus on various growth strategies such as new product launches and mergers & acquisitions as well as on patient awareness campaigns. For instance, in June 2013, Cook Medical launched Evolution Biliary Controlled-Release Uncovered Stent in the U.S. This stent is used to drain obstructed biliary ducts.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 – 2016

Forecast period

2017 – 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, UK, Germany, France, Italy, Spain, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the non-vascular stents market on the basis of product and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Gastrointestinal Stents

      • Biliary

      • Duodenal

      • Colonic

      • Pancreatic

      • Esophageal Stets

    • Pulmonary (Airway) Stents

      • Silicone Airway

      • Metallic Airway

    • Urological Stents

    • Others 

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified